RecruitingNCT07350499

Aspiration Thrombectomy Using the Symphony or Prodigy System

Long-Term CLinical Evaluation of Aspiration ThRombectomy Using the Symphony or ProdIgy Thrombectomy System - CLEAR-IT


Sponsor

Imperative Care, Inc.

Enrollment

750 participants

Start Date

Feb 13, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Subject is ≥ 18 years of age
  • Subject is willing and able to comply with the follow-up schedule specified in this protocol
  • Subject is willing and able to provide written informed consent prior to any study-related data collection
  • Subject has a planned procedure, involving the use of Imperative Care vascular devices within their intended use

Exclusion Criteria4

  • Subjects with any contraindications per the applicable Instructions for Use
  • Subject with life expectancy of less than 1 year
  • In the opinion of the Investigator, the patient is not a suitable candidate for intervention with Imperative Care devices
  • Subject who may be unable to complete study follow-up

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEProdigy Thrombectomy System

Removal of thrombus/emboli from blood vessels in the peripheral vasculature

DEVICESymphony Thrombectomy System

Removal of thrombus/emboli from blood vessels in the peripheral vasculature

DEVICESymphony Thrombectomy System

Removal of thrombus/emboli from the pulmonary vasculature


Locations(1)

Huntsville Hospital

Huntsville, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07350499


Related Trials